The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC).
 
Michal Sternschuss
Honoraria - Medison
Travel, Accommodations, Expenses - MSD
 
Nicolas Toumbacaris
No Relationships to Disclose
 
Jeeban Paul Das
No Relationships to Disclose
 
Thomas Powles
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; Merck; Merck Serono; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Dean F. Bajorin
Honoraria - Bristol-Myers Squibb/Medarex
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas (Inst)
 
Ritesh R Kotecha
Consulting or Advisory Role - Eisai; Eisai; Guidepoint Inc; Guidepoint Inc
Research Funding - Allogene Therapeutics (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Xencor (Inst)
 
Andrew Leonard Laccetti
Consulting or Advisory Role - Bayer; Guidepoint Global; Third Bridge
Research Funding - Bayer; ESSA; Johnson & Johnson/Janssen
 
Han Xiao
No Relationships to Disclose
 
Emily Feld
No Relationships to Disclose
 
Deaglan Joseph McHugh
Honoraria - OncLive
Consulting or Advisory Role - Progenics
 
Niamh M. Keegan
No Relationships to Disclose
 
Samuel A Funt
Employment - ByHeart (I)
Stock and Other Ownership Interests - 76Bio (I); Allogene Therapeutics; Doximity; IconOVir Bio (I); Kite, a Gilead company; Kronos Bio; Neogene Therapeutics (I); Urogen pharma (I); Vida Ventures (I)
Consulting or Advisory Role - BioNtech; Immunai; Merck
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Neil J. Shah
Honoraria - MedNet, LLC; MedNet, LLC; MJH Life Sciences
Consulting or Advisory Role - Exelixis; Graticule; Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst); Exelixis
Travel, Accommodations, Expenses - Merck
 
Gopa Iyer
Consulting or Advisory Role - Bicycle Therapeutics; Flare Therapeutics; Janssen; Loxo/Lilly; Mirati Therapeutics
Speakers' Bureau - Gilead Sciences; Lynx Group
Research Funding - Bayer (Inst); Debiopharm Group (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Seagen (Inst)
 
David H Aggen
Consulting or Advisory Role - Alphasights; Aptitude Health; Astellas Pharma; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Guidepoint Global Advisors; MJH Life Sciences; Seagen
Patents, Royalties, Other Intellectual Property - University of Illinois - Urbana Champaign
 
Min Yuen Teo
Consulting or Advisory Role - AstraZeneca; Janssen Oncology
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Pharmacyclics (Inst)
 
Irina Ostrovnaya
No Relationships to Disclose
 
Jonathan E. Rosenberg
Honoraria - Clinical Care Options; Medscape; MJH Life Sciences; NCCN/Pfizer; Peerview; Pfizer; Physicans' Education Resource; Research To Practice; UpToDate
Consulting or Advisory Role - Alligator Bioscience; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Century Therapeutics; Gilead Sciences; GlaxoSmithKline; Hengrui Pharmaceutical; Immunomedics; Imvax; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer/EMD Serono; QED Therapeutics; Roche/Genentech; Seagen; Tyra Biosciences
Research Funding - Acrivon Therapeutics; Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); QED Therapeutics (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Predictor of platinum sensitivity (Inst)